Inhaler
Latest Novartis AG Patents:
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
- Polyomavirus neutralizing antibodies
- Synthesis of prostate specific membrane antigen (PSMA) ligands
- Combination therapy using a chimeric antigen receptor
- Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamycin derivatives and uses thereof
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D579547
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,808
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,808
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)